JBN Biotech ApS: Financial statements 2020
CVR: 40685693
Source: annual report 2020, Danish Business Authority
30/07/2019 – 30/06/2020
JBN Biotech ApS (CVR 40685693) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -26,848 and a net result of DKK -646,053. Equity in the 2020 report amounted to DKK -606,053.
- Gross Profit
- DKK -26,848
- Profit/Loss
- DKK -646,053
- Equity
- DKK -606,053
- Total Assets
- DKK 35,763,527
- Employees
- 0
Official annual report
How creditworthy is JBN Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout JBN Biotech ApS
JBN Biotech ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jens Bredal Nielsen. The company is owned by Jens Bredal Nielsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -22,188 and a net result of DKK -222,807 compared with DKK -263,330 the year before. Equity in the 2025 report amounted to DKK 34,941,304.